Who Exports Torsemide from India — 117 Suppliers Behind a $18.2M Market
India's torsemide export market is supplied by 117 active exporters who collectively shipped $18.2M across 1,997 shipments. HETERO LABS LIMITED leads with a 58.0% market share, followed by AUROBINDO PHARMA LTD and MICRO LABS LIMITED. The top 5 suppliers together control 91.9% of total export value, reflecting a concentrated market structure.

Top Torsemide Exporters from India — Ranked by Export Value
HETERO LABS LIMITED is the leading torsemide exporter from India, holding a 58.0% share of the $18.2M market across 1,997 shipments from 117 exporters. The top 5 suppliers — HETERO LABS LIMITED, AUROBINDO PHARMA LTD, MICRO LABS LIMITED, CIPLA LIMITED, AUROBINDO PHARMA LIMITED — collectively control 91.9% of total export value, indicating a highly concentrated market. Individual shares are: HETERO LABS LIMITED (58.0%), AUROBINDO PHARMA LTD (17.0%), MICRO LABS LIMITED (10.6%), CIPLA LIMITED (4.4%), AUROBINDO PHARMA LIMITED (1.9%).
Top Torsemide Exporters from India
Ranked by export value · 117 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED TORSEMIDE TABLETTORSEMIDE TABSTORSEMIDE 20MG TABLET | $10.6M | 1 | 58.0% |
| 2 | AUROBINDO PHARMA LTD TORSEMIDE TABLETTORSEMIDE TABSTORSEMIDE 20MG TABLET | $3.1M | 2 | 17.0% |
| 3 | MICRO LABS LIMITED TOR 20MG 150 TAB TORSEMIDETORSINEX 20 TORSEMIDE 20MG TABLETS 3 XTORSINEX 20 ) | $1.9M | 12 | 10.6% |
| 4 | CIPLA LIMITED DYTOR - 10 TABLETS (TORSEMIDE TABLETS 10DYTOR 10 MG TABLETSDYTOR-10 TABLETS TORSEMIDE TABLETS 10 M | $805.9K | 2 | 4.4% |
| 5 | AUROBINDO PHARMA LIMITED TORSEMIDE TABLETTORSEMIDE TABSTORSEMIDE 20MG TABLET | $349.3K | 1 | 1.9% |
| 6 | LOTUS INTERNATIONAL TORSEMIDE IP 40MGTORSEMIDE IP 10MGTORSEMIDE IP 40 MG | $202.5K | 1 | 1.1% |
| 7 | MICRO LABS LTD TOR 20MG 150 TAB TORSEMIDETORSINEX 20 TORSEMIDE 20MG TABLETS 3 XTORSINEX 20 ) | $174.6K | 4 | 1.0% |
| 8 | SAVA HEALTHCARE LIMITED TOR 20MG 150 TAB TORSEMIDEDYTOR 10MG 1500 TAB TORSEMIDETOR 10MG 150 TAB TORSEMIDE USP | $165.8K | 1 | 0.9% |
| 9 | RECIPHARM PHARMASERVICES PRIVATE LIMITED TORSEMIDE TABLETTORSEMIDE TABSTORSEMIDE 20MG TABLET | $137.8K | 1 | 0.8% |
| 10 | SAGA LIFESCIENCES LIMITED TORSINEX 20 )TORSINEX 10 TORSEMIDE TABLETS 10MG 3X10S QTY- 3911.000PHARMA PRODUCTS: DIURIDE-20 TORSEMIDE TA | $106.8K | 1 | 0.6% |
| 11 | HEXA HEALTHCARE PVT LTD TOR 20MG 150 TAB TORSEMIDEDYTOR 10MG 1500 TAB TORSEMIDETOR 10MG 150 TAB TORSEMIDE USP | $99.4K | 1 | 0.5% |
| 12 | EDGE PHARMA PRIVATE LIMITED | $43.2K | 3 | 0.2% |
| 13 | HEXA HEALTH CARE PRIVATE LIMITED TOR 20MG 150 TAB TORSEMIDEDYTOR 10MG 1500 TAB TORSEMIDETOR 10MG 150 TAB TORSEMIDE USP | $33.5K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Torsemide exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| HETERO LABS LIMITED | Approved | Yes | Yes | 4 | Hetero Labs has received FDA approvals and holds WHO-GMP and EU-GMP certificatio |
| AUROBINDO PHARMA LIMITED | Approved | Yes | Yes | 11 | Aurobindo Pharma has multiple FDA approvals and holds WHO-GMP and EU-GMP certifi |
| MICRO LABS LIMITED | Approved | Yes | Yes | 2 | Micro Labs has received FDA approvals and holds WHO-GMP and EU-GMP certification |
| CIPLA LIMITED | Approved | Yes | Yes | 7 | Cipla has received FDA approvals and holds WHO-GMP and EU-GMP certifications. |
| SAVA HEALTHCARE LIMITED | Approved | Yes | Yes | Not Listed | Sava Healthcare holds FDA approval and WHO-GMP and EU-GMP certifications. |
| RECIPHARM PHARMASERVICES PRIVATE LIMITED | Approved | Yes | Yes | Not Listed | Recipharm holds FDA approval and WHO-GMP and EU-GMP certifications. |
| SAGA LIFESCIENCES LIMITED | Approved | Yes | Yes | Not Listed | Saga Lifesciences holds FDA approval and WHO-GMP and EU-GMP certifications. |
| LOTUS INTERNATIONAL | Approved | Yes | Yes | Not Listed | Lotus International holds FDA approval and WHO-GMP and EU-GMP certifications. |
TransData Nexus reviewed the regulatory standing of 8 leading Torsemide exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Torsemide sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts numerous pharmaceutical companies, including Aurobindo Pharma Limited, which is headquartered in Hyderabad. Aurobindo Pharma is a significant exporter of Torsemide, contributing $3.1 million (17.0%) to the total exports. The presence of such major players underscores Hyderabad's critical role in the production and export of bulk drugs like Torsemide.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to several leading pharmaceutical companies that specialize in the development and manufacturing of finished dosage forms. While specific data on Torsemide production in this cluster is limited, the area's emphasis on formulations suggests a potential role in the drug's manufacturing and export.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a crucial export gateway for India's pharmaceutical products. Mumbai, being a major commercial hub, facilitates the international distribution of pharmaceuticals. Cipla Limited, headquartered in Mumbai, is among the top exporters of Torsemide, contributing $0.8 million (4.4%) to the total exports. This highlights the region's significance in the export chain of pharmaceuticals like Torsemide.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is recognized as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth has been bolstered by favorable government policies and tax incentives, attracting numerous pharmaceutical companies. While specific data on Torsemide production in this cluster is not readily available, the area's extensive manufacturing capabilities suggest a potential role in its production.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 91.9% of Torsemide exports, it's advisable to explore partnerships with smaller manufacturers to mitigate supply chain risks.
- Engage with Hyderabad-Based Manufacturers: Considering Hyderabad's prominence in bulk drug production, collaborating with companies like Aurobindo Pharma could ensure a stable supply of Torsemide.
- Leverage Export Hubs: Utilize the export infrastructure of the Mumbai-Thane-Raigad region to facilitate efficient international distribution of Torsemide.
- Monitor Regulatory Compliance: Ensure that all sourcing partners adhere to the regulatory standards set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain product quality and compliance.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Torsemide exporters from India
Aurobindo Pharma Ltd — Aurobindo Pharma acquires Khandelwal Labs' non-oncology business
Aurobindo Pharma Ltd acquired the non-oncology branded generics business of Khandelwal Laboratories Pvt Ltd, enhancing its domestic formulation portfolio in key therapeutic areas. - IMPACT: This acquisition is expected to strengthen Aurobindo's position in the domestic market, potentially increasing its Torsemide export capacity.
Impact: This acquisition is expected to strengthen Aurobindo's position in the domestic market, potentially increasing its Torsemide export capacity.
Cipla Limited — Cipla acquires 21.05% stake in Achira Labs
Cipla Limited signed definitive agreements to acquire a 21.05% stake in Achira Labs Private Limited, aiming to develop affordable point-of-care medical test kits in India. - IMPACT: While this investment focuses on diagnostics, it may indirectly support Cipla's pharmaceutical operations, including Torsemide production, through enhanced diagnostic capabilities.
Impact: While this investment focuses on diagnostics, it may indirectly support Cipla's pharmaceutical operations, including Torsemide production, through enhanced diagnostic capabilities.
Hetero Labs Limited — Hetero Labs faces patent litigation in the U.S.
Hetero Labs Limited was named as an alleged infringer in a patent litigation case filed in the District of New Jersey, involving multiple pharmaceutical companies. (npe.law.stanford.edu) - IMPACT: Ongoing litigation may affect Hetero's export operations, including Torsemide, due to potential legal and financial implications.
Impact: Ongoing litigation may affect Hetero's export operations, including Torsemide, due to potential legal and financial implications.
Common Questions — Torsemide Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which torsemide supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, HETERO LABS LIMITED leads with 246 recorded shipments worth $10.6M. AUROBINDO PHARMA LTD (116 shipments) and MICRO LABS LIMITED (199 shipments) are also established high-volume exporters.
Q How many torsemide manufacturers are there in India?
India has 117 active torsemide exporters with a combined export market of $18.2M across 1,997 shipments to 51 countries. The top 5 suppliers hold 91.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for torsemide from India?
Average FOB unit price: $16.15 per unit, ranging from $0.00 to $7457.71. Average shipment value: $9.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 117 verified Indian exporters of Torsemide ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,997 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 51 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,997 Verified Shipments
117 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists